Details for New Drug Application (NDA): 062644
✉ Email this page to a colleague
The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 062644
Tradename: | CLEOCIN |
Applicant: | Pfizer |
Ingredient: | clindamycin palmitate hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 062644
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 062644
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLEOCIN | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 062644 | ANDA | Pharmacia & Upjohn Company LLC | 0009-0760 | 0009-0760-04 | 1 BOTTLE in 1 CARTON (0009-0760-04) / 100 mL in 1 BOTTLE |
CLEOCIN | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 062644 | ANDA | Greenstone LLC | 59762-0016 | 59762-0016-1 | 1 BOTTLE in 1 CARTON (59762-0016-1) / 100 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 75MG BASE/5ML | ||||
Approval Date: | Apr 7, 1986 | TE: | AA | RLD: | No |
Complete Access Available with Subscription